New Study Shows Promise for a Simpler Treatment for Generalized Anxiety Disorder
Definium Therapeutics has shared good news from their first major trial (called Voyage) of a new fast-dissolving tablet called DT120 […]
New Partnership in Switzerland to Improve Access to Testosterone Treatment for Men
Androlabs has teamed up with EffRx Pharmaceuticals to manage the distribution and promotion of Testavan in Switzerland. Testavan is a
Weekly Roundup: FDA Leadership Change, Breakthroughs in Rare Diseases, and New Treatments for Schizophrenia, Parkinson’s, and Obesity
This week in healthcare and pharmaceuticals, several important updates were announced. President Trump has selected a new candidate for the
Pharmaceutical News
Free Webinar: Learn How Scientists Track Medicine Quality and Safety
Would you like to know how experts check the quality of medicines to ensure they work safely and effectively? Join
Pharmaceutical News
Irish Pharmaceutical Company Expands Factories to Boost Production of Life-Saving Medicines
A company called SK pharmteco, based in the United States but operating in Ireland, has just opened two newly expanded
New Allergy Treatment Approved in Scotland for House Dust Mite Allergies
A new treatment called ACARIZAX (12 SQ-HDM SLIT) has been accepted by the Scottish Medicines Consortium (SMC) for adults in
Pharmaceutical News
SGS Expands French Laboratory to Support More Complex Medical Research
A well-known testing company called SGS has recently expanded its laboratory in Saint-Benoît, France, near Poitiers. This expansion adds 500
Pharmaceutical News
FDA Approves First Drug to Treat the Root Cause of Narcolepsy Type 1
The US Food and Drug Administration (FDA) has approved a new medication called Orzeyful (oveporexton) from Takeda, designed specifically to
NHS England approves new twice-daily treatment for rare kidney condition
NHS England has given the go-ahead for a new treatment called delayed-release mercaptamine bitartrate to be routinely prescribed for patients
First Patient Dosed in New Cancer Drug Trial for Advanced Skin Tumors
A company called Kupando has started the first human trial of a new experimental cancer drug called KUP101. This marks